Jahr Robert Charles

Chief Executive Officer

DirectorOfficer

Latest Insider Transactions

1 transactions (past 365 days)

OTLK
CEO
Award
$143K
100,000 shares @ $1.43
Filed 2026-07-23Trade 2026-07-21
Outlook Therapeutics, Inc.